Hims & Hers Health, Inc. (HIMS)

NYSE: HIMS · Real-Time Price · USD
41.03
-0.49 (-1.18%)
At close: Nov 7, 2025, 4:00 PM EST
41.29
+0.26 (0.63%)
After-hours: Nov 7, 2025, 7:59 PM EST
-1.18%
Market Cap9.34B
Revenue (ttm)2.21B
Net Income (ttm)133.79M
Shares Out 227.65M
EPS (ttm)0.54
PE Ratio76.43
Forward PE64.17
Dividendn/a
Ex-Dividend Daten/a
Volume28,931,953
Open40.74
Previous Close41.52
Day's Range39.34 - 41.27
52-Week Range19.15 - 72.98
Beta2.40
AnalystsHold
Price Target42.80 (+4.31%)
Earnings DateNov 3, 2025

About HIMS

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supp... [Read more]

Founded 2017
Employees 1,637
Stock Exchange NYSE
Ticker Symbol HIMS
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 12 analysts, the average rating for HIMS stock is "Hold." The 12-month stock price target is $42.8, which is an increase of 4.31% from the latest price.

Price Target
$42.8
(4.31% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Hims & Hers: GLP-1 Partnership Could Unlock Value

Hims & Hers Health reported strong 3Q25 revenue growth of 49% YoY, despite a GAAP EPS miss and shares falling post-earnings. HIMS is expanding its offerings, including testosterone and potential at-ho...

3 days ago - Seeking Alpha

HIMS CEO Says 'A Little Bit of Craziness' Is The Secret To Building A Global Health Platform

Hims & Hers Health Inc (NYSE:HIMS) isn't just chasing wellness trends — it's building a global health platform. At the company's third-quarter earnings call, CEO Andrew Dudum said the company's next p...

4 days ago - Benzinga

Hims & Hers Health, Inc. (HIMS) Q3 2025 Earnings Call Transcript

Hims & Hers Health, Inc. ( HIMS) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Bill Newby Andrew Dudum - Co-Founder, Chairman & CEO Yemi Okupe - Chief Financial Officer Conf...

4 days ago - Seeking Alpha

Hims & Hers Health Third-Quarter Revenue Jumps as Subscribers Grow

The telehealth platform said revenue rose 49% to $599 million in the latest quarter.

5 days ago - WSJ

Hims & Hers Stock Pops After Q3 Earnings: Here's Why

Hims & Hers Health, Inc. (NYSE:HIMS) shares popped after the company released its third-quarter earnings report after Monday's closing bell. Hims said it is in active discussions to make Novo Nordisk ...

5 days ago - Benzinga

Hims and Hers misses quarterly profit estimates

Hims and Hers Health missed Wall Street estimates for third-quarter profit on Monday, hit by increased product costs and reduced unit sales in the telehealth company's weight-loss business.

5 days ago - Reuters

Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the third quarter...

5 days ago - Business Wire

Struggling Healthcare Stock Ripe For Bull Notes

Shares of Hims & Hers Health (HIMS) are headed for their fourth-straight daily drop, down 2.4% to trade at $45.53 at last check, as investors look ahead to the company's third quarter results, due out...

9 days ago - Forbes

Hims & Hers: Use This Drop Before It's Too Late

Hims & Hers has experienced a hefty sell-off in recent weeks. This sell-off was mainly caused by short-term turbulence, and I expect the company to resolve these issues in the next quarter. HIMS needs...

14 days ago - Seeking Alpha

Hims & Hers: There's Opportunity In This Crash (Upgrade)

Hims & Hers offers a compelling "Buy" opportunity after a 30% pullback, despite recent growth concerns and insider selling. HIMS maintains strong long-term growth targets, aiming for $6.5 billion in r...

16 days ago - Seeking Alpha

Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks

Investors searching for the next Beyond Meat, Inc. (NYSE:BYND) — the latest poster child for explosive short squeezes — are eyeing the most shorted stocks as potential candidates for outsized rallies.

17 days ago - Benzinga

Hims & Hers Q3 Preview: Key Metrics I Want To See For Beating 2030 Guidance

I expect Hims & Hers Health, Inc. to show stabilizing ARPU around $54+ per user in Q3 despite the GLP-1 slowdown, which could signal meaningful upside to the company's conservative 2030 guidance. I'm ...

18 days ago - Seeking Alpha

Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright

Hims & Hers (HIMS) is emerging as a disruptive force in the obesity treatment market, challenging established GLP-1 drug makers. HIMS has aggressively captured market share, often operating in a legal...

19 days ago - Seeking Alpha

Hims & Hers Health: Roller Coaster Gift

Hims & Hers Health launched menopause and low testosterone products in the last month, expanding its addressable market and supporting its $6.5 billion 2030 revenue target. Recent product launches, in...

19 days ago - Seeking Alpha

Why Hims & Hers stock is failing to retain menopause gains and what comes next?

Hims & Hers Health Inc (NYSE: HIMS) started this week on a positive note after announcing its expansion into menopause-related treatments – a large and underserved market. However, the rally is fading...

22 days ago - Invezz

Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem

Hims & Hers Health Inc. (NYSE:HIMS) has become one of 2025's most surprising winners, up more than 150% year-to-date and over 200% in the past twelve months. But what's making Wall Street sit up this ...

23 days ago - Benzinga

Hims & Hers: Ramping Up A New Billion-Dollar Segment (Rating Upgrade)

I am upgrading Hims & Hers Health, Inc. to a Buy with an $80 price target, implying 30% upside. The new 'Hers' specialty in Menopause is expected to help the company drive over $1B in Hers segment rev...

23 days ago - Seeking Alpha

How HIMS Stock Rises To $120?

Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...

23 days ago - Forbes

Weight-loss drugs shook up the stock market. Menopause treatments could be next.

Hims & Hers is taking aim at menopause and perimenopause in an attempt to tap in to a huge and potentially highly lucrative market.

24 days ago - Market Watch

Hers Launches Menopause and Perimenopause Specialty, Taking the Next Step Toward $1B of Hers Revenue in 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the launch of a new specialty in women's health, offering access to aff...

24 days ago - Business Wire

Hims & Hers to Offer Treatments for Menopause, Perimenopause

Hims & Hers Health said it is now providing menopause care, marking the company's latest push into hormone-replacement therapies.

24 days ago - WSJ

Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results...

26 days ago - Business Wire

Hims & Hers: Why I'm Betting On HIMS Heading To $100

I see a clear path for Hims & Hers Health to reach $100 a share, and I plan to be there when it gets there. HIMS expects revenue growth to rebound, driven by weight loss and new health offerings, aimi...

26 days ago - Seeking Alpha

How Hims & Hers founder Joe Spector turned 10 failures into $1B idea

Listen and subscribe to The Big Idea with Elizabeth Gore on Apple Podcasts, Spotify, or wherever you find your favorite podcast. How do you break into a tough market and win?

4 weeks ago - Yahoo Finance

Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor's Office

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how...

4 weeks ago - Business Wire